InvestorsHub Logo
Followers 3
Posts 397
Boards Moderated 0
Alias Born 09/14/2010

Re: None

Thursday, 10/14/2010 11:31:19 AM

Thursday, October 14, 2010 11:31:19 AM

Post# of 130743
"Thirdly, the EP Health Sciences Division has multiple projects underway including the development, promotion, and marketing of new FDA approved medical devices, which could help alleviate pain and manage Post Traumatic Stress Disorder (PTSD). “We anticipate we will, in some cases, have exclusive marketing rights for certain products in the future,” explained President and CEO, Joe Valenzano. “Our mission at EP has always been to help those impacted by disability and pain in all the ways we possibly can. At EP, we have access to many resources gained over 40 years in the healthcare field with physicians, scientists, professional medical societies, and large health institutions.”

EPGL PR, September 30, 2010

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.